Delivery Order SPE2DB25D3012-SPE2DB25FWXPY
Award Date
5/27/25
Potential Completion Date
5/28/25
Potential Value
$21K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets, with a ceiling value of $9,807.11 and a completion date of July 24, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is registered in the System for Award Management (SAM.gov). The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that supports the U.S. military's medical needs. The contract is a...
This federal contract award is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $7,725.05. The contract is a delivery order, with a firm fixed-price pricing type, and has an ultimate completion date of September 23, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $9,340.11 and is a firm fixed-price delivery order with a completion date of February 5, 2024. This contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, which is a major pharmaceutical distributor to the U.S. government. The contract has a ceiling value of $3,157.98 and a completion date of June 17, 2024. It is a firm fixed price delivery order contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the supply of Valsartan-HCTZ 160-12.5 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $8,165.16. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is July 22, 2024. The contract was not set aside for any specific business type. Amerisourcebergen...
This federal contract award is for the delivery of 4,566,178,053 units of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The delivery order has a ceiling value of $3,327.84 and a completion date of October 23, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets to the Defense Logistics Agency (DLA), a major defense agency under the Department of Defense. The $1,731.54 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a large pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 24, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This contract award from the Defense Logistics Agency (DLA) is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets to the government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,106.77 and an ultimate completion date of January 6, 2022. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award is for the delivery of Valsartan-HCTZ 320-12.5 mg tablets in quantities of 90 to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,979.05 and an ultimate completion date of May 28, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. Amerisourcebergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,985.62, is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 7, 2025. It is not associated with any set-aside designation, indicating open competition. Amerisourcebergen holds a significant...